Instagram Carousel Ad.png

DID YOU KNOW?

The FDA issues a Warning Letter when a manufacturer has significantly violated the FDA’s safety regulations and quality control measures. The overwhelming majority of Warning Letters are issued to pharmaceutical manufacturers in China and India.

capsules-header.jpg

TAKE THE POLL!

Should the FDA ban imports of generic medicines from foreign manufacturers in China and India that have received a Warning Letter?

Question 1

Should the FDA test generic medicines from foreign manufacturers in China and India that have received a Warning Letter?

Question 2

Should the FDA conduct an in-person inspection of a foreign manufacturer in China and India that has received a Warning Letter before they are allowed to export generic medicines to the U.S.?

Question 3

Should retail pharmacies and hospitals be allowed to give Americans generic drugs from foreign manufacturers in China and India that have received a Warning Letter?

Question 4

DID YOU KNOW? Nearly 90 percent of all prescriptions are generic drugs, but the U.S. imports the majority of its generic drugs from heavily subsidized foreign facilities in China and India that are violating the Food and Drug Administration’s (FDA) regulations for safety.

Should the U.S. government implement policies to make the U.S. a leader manufacturing generic medicines?

Question 5

Thanks for your responses!